Afya (AFYA)
(Delayed Data from NSDQ)
$18.17 USD
0.00 (0.00%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $18.19 +0.02 (0.11%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$18.17 USD
0.00 (0.00%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $18.19 +0.02 (0.11%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth B Momentum A VGM
Zacks News
Do Options Traders Know Something About Afya (AFYA) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Afya (AFYA) stock based on the movements in the options market lately.
Should Value Investors Buy Afya (AFYA) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
AFYA vs. BFAM: Which Stock Is the Better Value Option?
by Zacks Equity Research
AFYA vs. BFAM: Which Stock Is the Better Value Option?
Afya (AFYA) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Afya (AFYA) delivered earnings and revenue surprises of 17.02% and 6.19%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Roblox (RBLX) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Roblox (RBLX) delivered earnings and revenue surprises of 18.87% and 0.78%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Universal Technical Institute (UTI) Lags Q2 Earnings Estimates
by Zacks Equity Research
Universal Technical (UTI) delivered earnings and revenue surprises of -6.67% and 4.05%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Lincoln Educational Services Corporation (LINC) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Lincoln Educational Services (LINC) delivered earnings and revenue surprises of 200% and 6.23%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
AFYA vs. LOPE: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
AFYA vs. LOPE: Which Stock Is the Better Value Option?
Afya (AFYA) Suffers a Larger Drop Than the General Market: Key Insights
by Zacks Equity Research
The latest trading day saw Afya (AFYA) settling at $18.13, representing a -1.47% change from its previous close.
Afya (AFYA) Laps the Stock Market: Here's Why
by Zacks Equity Research
Afya (AFYA) closed at $20.74 in the latest trading session, marking a +1.52% move from the prior day.
Lifetime Brands (LCUT) Misses Q4 Earnings Estimates
by Zacks Equity Research
Lifetime Brands (LCUT) delivered earnings and revenue surprises of -9.38% and 3.39%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Toro (TTC) Lags Q1 Earnings Estimates
by Zacks Equity Research
Toro (TTC) delivered earnings and revenue surprises of -3.03% and 0.50%, respectively, for the quarter ended January 2024. Do the numbers hold clues to what lies ahead for the stock?
Afya (AFYA) Stock Slides as Market Rises: Facts to Know Before You Trade
by Zacks Equity Research
Afya (AFYA) closed the most recent trading day at $20.23, moving -0.3% from the previous trading session.
Why Afya (AFYA) Dipped More Than Broader Market Today
by Zacks Equity Research
In the most recent trading session, Afya (AFYA) closed at $20.44, indicating a -0.68% shift from the previous trading day.
Strategic Education (STRA) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Strategic Education (STRA) delivered earnings and revenue surprises of 22.63% and 1.59%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Afya (AFYA) Advances While Market Declines: Some Information for Investors
by Zacks Equity Research
Afya (AFYA) reachead $20.05 at the closing of the latest trading day, reflecting a +0.3% change compared to its last close.
Afya (AFYA) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Afya (AFYA) closed the most recent trading day at $19.85, moving +1.17% from the previous trading session.
Afya (AFYA) Beats Stock Market Upswing: What Investors Need to Know
by Zacks Equity Research
Afya (AFYA) concluded the recent trading session at $20.51, signifying a +1.13% move from its prior day's close.
Afya (AFYA) Advances While Market Declines: Some Information for Investors
by Zacks Equity Research
In the closing of the recent trading day, Afya (AFYA) stood at $21.02, denoting a +0.57% change from the preceding trading day.
Afya (AFYA) Rises As Market Takes a Dip: Key Facts
by Zacks Equity Research
Afya (AFYA) closed at $20.44 in the latest trading session, marking a +1.79% move from the prior day.
PRDO or AFYA: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PRDO vs. AFYA: Which Stock Is the Better Value Option?
PRDO vs. AFYA: Which Stock Is the Better Value Option?
by Zacks Equity Research
PRDO vs. AFYA: Which Stock Is the Better Value Option?
Wall Street Analysts Think Afya (AFYA) Is a Good Investment: Is It?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Afya (AFYA) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
PRDO or AFYA: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PRDO vs. AFYA: Which Stock Is the Better Value Option?
Afya (AFYA) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Afya (AFYA) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?